The structure and function of CD26 in the T-cell immune response
- PMID: 9553764
- DOI: 10.1111/j.1600-065x.1998.tb01571.x
The structure and function of CD26 in the T-cell immune response
Abstract
CD26 is a widely distributed 110 kD cell-surface glycoprotein with known dipeptidyl-peptidase IV (DPP-IV) activity in its extracellular domain. This ecto-enzyme is capable of cleaving amino terminal dipeptides from polypeptides with either L-proline or L-alanine in the penultimate position. On human T cells, CD26 expression appears late in thymic differentiation and is preferentially restricted to the CD4+ helper/memory population, and CD26 can deliver a potent co-stimulatory T-cell activation signal. The cDNA sequence of CD26 predicts a type II membrane protein with only 6 amino acids in its cytoplasmic region, suggesting that, in addition to DPP-IV enzyme activity, other signal-inducing molecules may be associated with CD26. Considerable evidence exists that CD26 interacts, presumably in its extracellular domain, with both CD45, a protein tyrosine phosphatase, and adenosine deaminase (ADA), each of which is capable of functioning in a signal transduction pathway. In addition, CD26 is the receptor for ADA, and ADA on the cell surface is involved in an important immunoregulatory mechanism by which released ADA binds to the cell-surface ADA. This multifunctional molecule may be involved in cell migration and the HIV-1-associated loss of CD4+ cells through the process of programmed cell death. Thus, CD26 appears to play a key role in a number of aspects of lymphocyte function.
Similar articles
-
Good or evil: CD26 and HIV infection.J Dermatol Sci. 2000 Apr;22(3):152-60. doi: 10.1016/s0923-1811(99)00081-x. J Dermatol Sci. 2000. PMID: 10698152 Review.
-
Role of CD26 for CD4 memory T cell function and activation.Hum Cell. 1996 Sep;9(3):153-62. Hum Cell. 1996. PMID: 9183643 Review.
-
Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity.Eur J Biochem. 1996 Jul 15;239(2):248-58. doi: 10.1111/j.1432-1033.1996.0248u.x. Eur J Biochem. 1996. PMID: 8706727
-
Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminase.Biochem Pharmacol. 1996 Dec 13;52(11):1757-65. doi: 10.1016/s0006-2952(96)00597-7. Biochem Pharmacol. 1996. PMID: 8986139
-
Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway.Immunol Rev. 1998 Feb;161:43-53. doi: 10.1111/j.1600-065x.1998.tb01570.x. Immunol Rev. 1998. PMID: 9553763 Review.
Cited by
-
Biological evaluation of RBx-0128, a potent and selective dipeptidyl peptidase-IV inhibitor in type 2 diabetes genetic model.Indian J Pharmacol. 2012 Nov-Dec;44(6):759-64. doi: 10.4103/0253-7613.103298. Indian J Pharmacol. 2012. PMID: 23248408 Free PMC article.
-
Dipeptidyl peptidase-4 inhibitor might exacerbate Graves' disease: A multicenter observational case-control study.J Diabetes Investig. 2021 Nov;12(11):1978-1982. doi: 10.1111/jdi.13578. Epub 2021 Jun 16. J Diabetes Investig. 2021. PMID: 33998766 Free PMC article.
-
A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells.J Exp Med. 1999 Aug 2;190(3):311-22. doi: 10.1084/jem.190.3.311. J Exp Med. 1999. PMID: 10430620 Free PMC article.
-
Human Coronavirus Cell Receptors Provide Challenging Therapeutic Targets.Vaccines (Basel). 2023 Jan 13;11(1):174. doi: 10.3390/vaccines11010174. Vaccines (Basel). 2023. PMID: 36680018 Free PMC article. Review.
-
The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency.J Exp Med. 2000 Nov 6;192(9):1223-36. doi: 10.1084/jem.192.9.1223. J Exp Med. 2000. PMID: 11067872 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous